Skip to main content
. Author manuscript; available in PMC: 2017 May 1.
Published in final edited form as: J Affect Disord. 2016 Feb 10;195:172–179. doi: 10.1016/j.jad.2016.02.031

Table 3.

Comparisons of clinical outcome changes (week 0 – week 4) between taVNS and sham tsVNS groups combining hospitals 1 & 2. 95% indicates the treatment effect as indicated by outcome change between the real and sham taVNS (taVNS (pre-post) minus sham taVNS (pre-post).

P-value Lower 95% CI Upper 95% CI Effect size
HAMD < 0.0001 4.5 8.3 0.57
HAMA <0.0001 1.6 5.6 0.3
SAS 0.01 0.5 7.2 0.2
SDS <0.0001 5.5 12.4 0.44